Table 4 Expression levels of miRNAs targeting i.a. TYMS mRNA in cancer
From: MALAT1-miRNAs network regulate thymidylate synthase and affect 5FU-based chemotherapy
miRNA | Level†| Cancers‡ | References |
|---|---|---|---|
miR-140-3p | Down | CRC tissues | Chen et al. (2020c) |
| Â | Down | CRC tissues, SW480 and HCT116 cell lines | Jiang et al. (2019a) |
| Â | Down | Primary tumor tissues of CRC patients | Piepoli et al. (2012) |
| Â | Down | Liver metastatic vs none-metastatic CRC | Liu et al. (2021) |
| Â | Down | GC tissues and cell lines | Wang et al. (2021a) |
| Â | Down | GC tissues and five cell lines | Chen et al. (2021) |
| Â | Down | ESCC tissues and five cell lines | Wang et al. (2021d) |
| Â | Down | ESCC tissues and five cell lines | Chen et al. (2020d) |
| Â | Down | NSCLC (LUAD) tissues and five cell lines (i.a. A549) | Wang et al. (2021f) |
| Â | Down | NSCLC (LUAD): four cell lines (i.a. A549, H1299) | Wu et al. (2020) |
| Â | Down | NSCLC tissues and three cell lines (i.a. A549, H1299) | Hu et al. (2020) |
| Â | Down | NSCLC (SqCLC) tissues, stage III vs II vs I, four cell lines | Huang et al. (2019a) |
| Â | Down | NSCLC tissues | Dong et al. (2016) |
| Â | Down | Lung cancer tissues and six cell lines (i.a. A549) | Kong et al. (2015) |
| Â | Down | BLCA tissues and four cell lines (i.a. T24) | Yuan et al. (2021) |
| Â | Down | BRCA tissues stage I-IV | Dou et al. (2021) |
| Â | Down | BRCA tissues, MCF-7 (ER+) and MDA-MB-453 (HER2+) | Zhou et al. (2019) |
| Â | Down | HCC tissues | Gao et al. (2021b) |
| Â | Down | CeCa tissues | Wang et al. (2022a) |
| Â | Down | CeCa tissues | Wang et al. (2021g) |
| Â | Down | OVCA tissues | Qiao et al. (2021) |